Source: Eur Respir J 2016; 48: 880-888
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Lipworth Brian, Wedzicha Jadwiga, Devereux Graham, Vestbo Jørgen, Dransfield Mark T.. Beta-blockers in COPD: time for reappraisal. Eur Respir J 2016; 48: 880-888

Member's Comments

No comment yet.

Related content which might interest you: Beta-blockers and COPD: the show must go on Source: Eur Respir J 2016; 48: 600-603 Year: 2016 Is the coprescription of Beta-blockers and Beta2-agonists justified in patients with coexisting COPD and CHF? Source: Annual Congress 2009 - Beta-blockers may now be beneficial in asthma and COPD Year: 2009 Is it time to give up on “self-management” of COPD exacerbations? Source: Eur Respir J, 55 (1) 1902102; 10.1183/13993003.02102-2019 Year: 2020 Antibiotics in exacerbations of COPD: lessons from the past Source: Eur Respir J 2004; 24: 896-897 Year: 2004 Clinical and inhaled drug profile of COPD patients with indication for beta-blockers who are on beta-blockers Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Antibiotics in COPD exacerbations: practice and evidence Source: Breathe 2009; 5: 299-301 Year: 2009 Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future? Source: Eur Respir J, 51 (1) 1702577; 10.1183/13993003.02577-2017 Year: 2018 Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future? Source: Eur Respir J, 51 (1) 1701312; 10.1183/13993003.01312-2017 Year: 2018 Pulmonary rehabilitation following hospitalisation for acute exacerbation of COPD: Fact or fiction? Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013 Cardiac disease from accelerated FEV1 decline and acute exacerbations: time to rethink comorbidities in COPD Source: Eur Respir J, 57 (3) 2004008; 10.1183/13993003.04008-2020 Year: 2021 Evolving use of long-term NIV in COPD: Are we getting it right Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes Year: 2013 Methods for therapeutic trials in COPD: lessons from the TORCH trial Source: Eur Respir J 2009; 34: 1018-1023 Year: 2009 The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS Source: International Congress 2014 – COPD exacerbations Year: 2014 Dissecting COPD exacerbations: time to rethink our definition Source: Eur Respir J, 50 (3) 1701432; 10.1183/13993003.01432-2017 Year: 2017 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Rethinking COPD Exacerbations: a global patient perspective Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases Year: 2021 Statins and outcome of COPD patients after hospitalization for COPD exacerbations Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010 Improving symptomology in COPD: which therapy would you choose, a brochodilator or pulmonary rehabilitation? Source: International Congress 2019 – Hot topics in pulmonary rehabilitation Year: 2019